New aspects of the pathogenesis of placental insufficiency
- Authors: Zefirova T.P1, Zhelezova M.E1
-
Affiliations:
- Kazan State Medical Academy - a branch of the Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 6 (2018)
- Pages: 46-49
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/95046
- DOI: https://doi.org/10.26442/2075-1753_2018.6.46-49
- ID: 95046
Cite item
Full Text
Abstract
Placental insufficiency complicates the significant amount of pregnancies and leads to a hypoxia and fetal growth retardation. At uniformity of the clinical manifestations, a placental insufficiency is a multifactorial state. The considerable reason of a placental disfunction is halting of rheological properties of blood. Flowability of blood worsens at an anemic syndrome and a syndrome of hemoconcentration, it is necessary to consider at the choice of therapy at women with similar states. Other reason of alteration of a placenta is an activation of mother’s thrombocytes. Dipiridamole positively influences a hemorheology and reduces activity of thrombocytes therefore it can be used for prevention and treatment of a placental insufficiency to the categories of women listed above.
Full Text
##article.viewOnOriginalSite##About the authors
T. P Zefirova
Kazan State Medical Academy - a branch of the Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
Email: tzefirova@gmail.com
д-р мед. наук, проф. каф. акушерства и гинекологии №1 420012, Russian Federation, Kazan, ul. Mushtari, d. 11
M. E Zhelezova
Kazan State Medical Academy - a branch of the Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federationканд. мед. наук, доц. каф. акушерства и гинекологии №1 420012, Russian Federation, Kazan, ul. Mushtari, d. 11
References
- Morgan T.K. Role of the Placenta in Prenerm Birth: A Review. Am J Perinatol 2016; 33 (3): 258-66.
- Lithell U.B, Vagero D, Koupilova I, Leon D.A. Social determinants of birthweight, ponderal index and gestational age in Sweden in the 1920s and the 1980s. Acta Paediatr 1999; 88 (4): 445-53.
- John V.I, Tsilou E, Fisher S et al. Placental Origins of Adverse Pregnancy Outcomes: Potential Molecular Targets - An Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Am J Obstet Gynecol 2016; 215: 1-46.
- Ройтман Е.В., Фирсов Н.Н., Дементьева М.Г. Термины, понятия и подходы к исследованиям реологии крови в клинике. Тромбоз, гемостаз и реология. 2000; 3 (3): 5-12.
- Gonzales G.F, Steenland K, Tapia V. Maternal hemoglobin level and fetal outcome at low and high altitudes. Am J Physiol RegulIntegr Comp Physiol 2009; 297: 1477-85.
- Муравьев А.В., Кислов Н.В., Тихомирова И.А. и др. Рос. журн. биомеханики. 2013; 17 (2, 60: 75-83.
- Soliman A.A, Csorba R, Yilmaz A et al. Rheologic results and their correlation to hemostatic changes in patients with moderate and severe preeclampsia: an observational cross-sectional study. Clin Hemorheol Microcirc 2015; 59 (1): 1-15.
- Cordina M, Bhatti S, Fernandez M et al. Association between maternal haemoglobin at 27-29 weeks’ gestation and intrauterine growth restriction. Рregnancy Hypertens 2015; 5 (4): 339-45.
- Aranda N, Hernández-Martínez C, Arija V et al. Haemoconcentration risk at the end of pregnancy: effects on neonatal behaviour. Public Health Nutr 2017; 20 (8): 1405-13.
- Rao R, Georgieff M.K. Early nutrition and brain development. In the Effects of Early Adversity on Neurobehavioral. Psychology Press 2015; May 7: 346.
- Зефирова Т.П., Сабиров И.Х., Железова М.Е. Влияние нарушений реологических свойств крови матери на внутриутробное развитие плода. Эффективная фармакотер. 2016; 14: 22-6.
- Салов И.А., Лысенко Л.В., Маршалов Д.В., Петренко А.П. Зависимость тканевой оксигенации от уровня гемоглобина у беременных и рожениц с анемией. Фундаментальные исследовния. 2014; 4 (1): 163-6.
- Sharawy N. Effects of haemoglobin levels on the sublingual microcirculation in pregnant women. J Clinl Hemorheol Microcircul 2016; 64 (2): 205-12.
- Dodd J.M, McLeod A, Windrim R.C, Kingdom J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev 2013; 7: CD006780.
- WHO recommendations for prevention and treatment of preeclampsia and eclampsia - World Health Organization. 2011.
- Cohen H, O'Brien P. Disorders of Thrombosis and Hemostasis in Pregnancy. A Guide to Management 2015; 64 (1): 435-8.
- Петрухин В.А., Новикова С.В., Павлова Т.В., Леонова В.Ю. Акушерство и гинекология. 2017; 3 (2): 44-8.
- Adam S, Elfeky O, Kynhal V et al. Rewiev: Fetal-maternal communication via extracellular vesicles - Implications for complications of pregnancies. Placenta 2017; 54: 83-8.
- Kohli S, Isermann B. Placental hemostasis and sterile inflammation: New insights into gestational vascular disease. Thromb Res 2017; 151: 30-3.
Supplementary files
